Work

Durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer: Preliminary results from the Bladder Cancer Signal Seeking Trial (BLASST)-2.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.6_suppl.507

Authors: Xiao X. Wei, Bradley Alexander McGregor, Richard J. Lee, Xin Gao, Kerry L. Kilbridge, Mark A. Preston, Matthew Mossanen, Matthew D. Ingham, Graeme S. Steele, Alyssa Klein, Eliezer Mendel Van Allen, Mariano Severgnini, Marios Giannakis, Guru Sonpavde

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women's Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3008737262

Cites:

Cited by: 20

Related to: 10